Passage Bio, Inc. (Nasdaq: PASG) has shared updated findings from its ongoing Phase 1/2 upliFT-D clinical trial, which ...

It’s easy to view cognitive decline as an inevitable slide that we are powerless to fight. But knowing the early signs - ...

As Lamborn prepares to leave office, we are most grateful for his support. His support of these signed bills advances the ...

Is it dementia? A popular neurologist uses five simple tests of cognitive function to help gauge the health of a patient's ...